A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer

NCT06512051 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

248

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Non-small Cell Lung Cancer

Interventions

DRUG: SHR-A2102 for Injection
DRUG: Adebrelimab Injection
DRUG: Cisplatin injection
DRUG: Carboplatin injection
DRUG: Bevacizumab Injection

Sponsor

Shanghai Hengrui Pharmaceutical Co., Ltd.